DexCom Newsroom

Dexcom's Stock Downgrade: A Temporary Setback or a Buying Opportunity?

TipRanks01:59 ET

DexCom Analyst Ratings

BenzingaJul 29 11:59 ET

Dexcom's Strong Market Position and Growth Potential Affirm Buy Rating Despite Initial Rebate Confusion

TipRanksJul 29 06:41 ET

Barclays Maintains DexCom(DXCM.US) With Hold Rating, Maintains Target Price $113

Moomoo NewsJul 29 04:32 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: MacroGenics (MGNX) and Dexcom (DXCM)

TipRanksJul 28 21:34 ET

DexCom Price Target Cut to $75.00/Share From $120.00 by Morgan Stanley

Dow JonesJul 26 14:01 ET

BTIG Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $120

Moomoo NewsJul 26 08:34 ET

Oppenheimer Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $115

Moomoo NewsJul 26 08:34 ET

RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $145

Moomoo NewsJul 26 07:36 ET

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Tenaya Therapeutics (TNYA) and Cue Biopharma (CUE)

TipRanksJul 26 07:07 ET

DexCom Analyst Ratings

BenzingaJul 26 06:51 ET

Dexcom (DXCM) Gets a Buy From RBC Capital

TipRanksJul 26 06:51 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ovid Therapeutics (OVID) and Dexcom (DXCM)

TipRanksJul 26 06:39 ET

Raymond James Adjusts Price Target on DexCom to $115 From $160

MT NewswiresJul 26 06:38 ET

Dexcom: A Cautious Hold Amid Competitive Challenges and Operational Headwinds

TipRanksJul 26 06:35 ET

CCORF Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $145

Moomoo NewsJul 23 07:38 ET

DexCom Analyst Ratings

BenzingaJul 23 07:34 ET

Dexcom's Market Leadership and Strategic Growth Opportunities Affirm Buy Rating

TipRanksJul 23 06:54 ET

Leerink Adjusts Price Target on DexCom to $151 From $161

MT NewswiresJul 17 09:26 ET

DexCom Analyst Ratings

BenzingaJul 15 12:51 ET